#safetyprofile — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #safetyprofile, aggregated by home.social.
-
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
“Given the immune-mediated and unpredictable nature of non-segmental vitiligo, holistic therapeutic management including early diagnosis, appropriate treatment and…
#Europe #EU #EuropeanCommission #AbbVie #adolescentpatients #RINVOQ #safetyprofile
https://www.europesays.com/europe/105530/ -
SCENESSE® approved for EPP in Canada
Clinuvel Pharmaceuticals Limited Health Canada NOC enables treatment for porphyria, metabolic disorder MELBOURNE, Australia, July 13, 2026 (GLOBE…
#Canada #adultpatients #afamelanotide #Australia #CLINUVEL #CLINUVELPHARMACEUTICALS #DennisWright #erythropoieticprotoporphyria #Europe #HealthCanada #Melbourne #safetyprofile #specialaccess #SpecialtyCenters
https://www.europesays.com/canada/127400/ -
https://www.europesays.com/ie/578856/ Compass Pathways Eyes 2027 Launch as Psilocybin Depression Data Holds Up #ChiefCommercialOfficerLoriEnglebert #CompassPathways #Depression #Éire #fda #GuyGoodwin #Health #IE #Ireland #KabirNath #MentalHealth #MentalHealth #participants #PsilocybinTherapy #SafetyProfile #TreatmentResistantDepression
-
https://www.europesays.com/uk/1074278/ Compass Pathways Clears Another Hurdle – Builds Stronger FDA Case For Its Much-Awaited Depression Therapy #CMPS #Compass #CompassPathways #DepressionSymptoms #FDA #Health #MentalHealth #ResponseRate #SafetyProfile #UK #UnitedKingdom
-
https://www.europesays.com/ie/573428/ Compass Pathways Clears Another Hurdle – Builds Stronger FDA Case For Its Much-Awaited Depression Therapy #CMPS #Compass #CompassPathways #DepressionSymptoms #Éire #fda #Health #IE #Ireland #MentalHealth #MentalHealth #ResponseRate #SafetyProfile
-
Can-Fite Secures Japanese Patent Allowance for Namodenoson’s Anti-Obesity Technology
Can-Fite BioPharma Ltd. The allowed Patent strengthens protection in one of the world’s largest pharmaceutical markets and further…
#EuropeSays #Japan #JP #AdenosineReceptor #CANF #Company #drugcandidate #globalintellectualpropertyportfolio #inflammatorydiseases #IntellectualProperty #InternationalJournalofObesity #JapanPatentOffice #Japanese #receptoragonists #safetyprofile #theCompany
https://www.europesays.com/japan/48352/ -
Sanofi Rare Disease Pipeline Progress Puts Recent Share Price Weakness In Focus
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
#France #FR #Europe #EU #Sanofi #neurologicalsymptoms #raredisease #safetyprofile #type3Gaucherdisease
https://www.europesays.com/france/26627/ -
https://www.europesays.com/dk/88745/ Semaglutide MASH Data Broadens Novo Nordisk Case For Undervalued Shares #JapanesePatients #LiverDisease #MASH #MenopausalWomen #NovoNordisk #SafetyProfile #SimplyWallSt #StockTrades
-
Sanofi’s Efdoralprin Alfa Data Add Rare Disease Angle To Growth Story
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Sanofi…
#France #FR #Europe #EU #Sanofi #AAT #investmentdecisions #plasmatherapy #respiratorydisease #safetyprofile
https://www.europesays.com/france/17332/ -
https://www.europesays.com/dk/68041/ Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study #berlin #CMIC #CMICIII #DukeUniversity #Germany #HeartFailure #HeartRhythmSociety #InvasiveApproach #LeftVentricularEjectionFraction #MicrocurrentTherapy #NewYorkHeartAssociation #OutpatientProcedure #SafetyProfile
-
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
High Impact Session presented at Heart Rhythm Society’s Congress in Chicago First time showing results of new L…
#Germany #DE #Europe #EU #Europa #Berlin #CMIC #CMIC-III #DukeUniversity #heartfailure #HeartRhythmSociety #Invasiveapproach #LeftVentricularEjectionFraction #microcurrenttherapy #NewYorkHeartAssociation #outpatientprocedure #safetyprofile
https://www.europesays.com/germany/7427/ -
https://www.europesays.com/dk/66731/ Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes #adolescents #BloodSugarControl #Children #ClinicalTrial #GlycaemicControl #JacobMartin #NovoNordisk #ozempic #PIONEERTEENS #SafetyProfile #TreatmentOptions #Type2Diabetes
-
https://www.europesays.com/dk/66717/ Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes #adolescents #BloodSugarControl #Children #ClinicalTrial #GlycaemicControl #JacobMartin #NovoNordisk #ozempic #PIONEERTEENS #SafetyProfile #TreatmentOptions #Type2Diabetes
-
Implantica announces landmark RefluxStop® study of 602 patients across 22 European centers, with up to 6.75-year follow-up, published in Nature’s Scientific Reports
VADUZ, Liechtenstein, April 21, 2026 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of intr…
#Europe #EU #acidreflux #European #FDAapproval #GERDpatients #hiatalhernia #ImplanticaAG #milestonestudy #outcomesstudy #safetyprofile #ScientificReports #SebastianSchoppmann
https://www.europesays.com/europe/18704/ -
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically…
#NewsBeep #News #Medication #Development #Health #Lipocine #LPCN #oraldelivery #posthocanalysis #PostpartumDepression #proprietarytechnologyplatform #psychiatricconditions #safetyprofile #TheCompany #UK #UnitedKingdom
https://www.newsbeep.com/uk/510051/ -
https://www.europesays.com/ie/416915/ Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression #Development #Éire #Health #IE #Ireland #Lipocine #LPCN #Medication #OralDelivery #PostHocAnalysis #PostpartumDepression #ProprietaryTechnologyPlatform #PsychiatricConditions #SafetyProfile #TheCompany
-
https://www.europesays.com/uk/867378/ Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression #Development #Health #Lipocine #LPCN #Medication #OralDelivery #PostHocAnalysis #PostpartumDepression #ProprietaryTechnologyPlatform #PsychiatricConditions #SafetyProfile #TheCompany #UK #UnitedKingdom
-
C++ Compiler Support Status for C++26
https://cppstat.dev/?tags=cpp26,gcc
#cc
#cpp
#compiler
#gcc
#gnucompilercollection
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
C++ Compiler Support Status for C++26
https://cppstat.dev/?tags=cpp26,gcc
#cc
#cpp
#compiler
#gcc
#gnucompilercollection
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
C++ Compiler Support Status for C++26
https://cppstat.dev/?tags=cpp26,gcc
#cc
#cpp
#compiler
#gcc
#gnucompilercollection
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
C++ Compiler Support Status for C++26
https://cppstat.dev/?tags=cpp26,gcc
#cc
#cpp
#compiler
#gcc
#gnucompilercollection
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
Prof Bjarne Stroustrup's book, 'A Tour of C++' 3rd edition is the best book to get started with.
#cc
#cpp
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software
#stroustrup
#future -
Prof Bjarne Stroustrup's book, 'A Tour of C++' 3rd edition is the best book to get started with.
#cc
#cpp
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software
#stroustrup
#future -
Working on something interesting using C++ ?
Share with the community.
https://www.reddit.com/r/cpp/comments/10qp8pa/c_show_and_tell_february_2023/#cc
#cpp
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
Working on something interesting using C++ ?
Share with the community.
https://www.reddit.com/r/cpp/comments/10qp8pa/c_show_and_tell_february_2023/#cc
#cpp
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
Safety Profiles: Type-and-resource Safe programming in Standard C++
Bjarne Stroustrup (Columbia) and Gabriel Dos Reis.https://www.open-std.org/jtc1/sc22/wg21/docs/papers/2023/p2816r0.pdf
#cc
#cpp
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software -
Safety Profiles: Type-and-resource Safe programming in Standard C++
Bjarne Stroustrup (Columbia) and Gabriel Dos Reis.https://www.open-std.org/jtc1/sc22/wg21/docs/papers/2023/p2816r0.pdf
#cc
#cpp
#cplusplus
#isocpp
#isocplusplus
#safetyprofile
#typesafety
#resourcesafety
#programming
#cplusplusprogramming
#software